United States v. Clemens

793 F. Supp. 2d 236, 2011 U.S. Dist. LEXIS 66554, 2011 WL 2489743
District Court, District of Columbia·Decided June 23, 2011·No. Criminal Action 10-223 (RBW)·Published·Cited by 18 cases

Opinion

MEMORANDUM OPINION

REGGIE B. WALTON, District Judge.

William R. Clemens, the defendant in this criminal case, has been indicted on various criminal charges related to testimony that he provided to the House Committee on Oversight and Government Reform in February of 2008. See Indictment (“Indict.”) at 12-19. 1 On or about Febru *238 ary 10, 2011, the defendant served DLA Piper U.S. LLP (“DLA Piper”) with a subpoena duces tecum pursuant to Federal Rule of Criminal Procedure 17(c), Memorandum in Support of Non-Party DLA Piper’s Motion to Quash Subpoena (“DLA Piper’s Mem.”) at 1, seeking, inter alia, “all interview summaries, notes, and memoranda” pertaining to Jose Canseco, Brian McNamee, and Kirk Radomski that are “related to the ‘Report to the Commissioner of Baseball of an Independent Investigation into the Illegal Use of Steroids and Other Performance Enhancing Substances by Players in Major League Baseball,” id., Ex. 3 (Subpoena Duces Tecum to DLA Piper U.S. LLP) at 3. DLA Piper then moved to quash the subpoena, arguing that “the handwritten or typed notes taken during interviews” conducted by DLA Piper of these three individuals, as well as the “memoranda prepared after [the] interviews summarizing the substance of the[se] interviews .... constitute classic attorney work product.” DLA Piper’s Mem. at 2. After careful consideration of DLA Piper’s motion to quash, the defendant’s memorandum in opposition to DLA Piper’s motion, DLA Piper’s brief in reply to the defendant’s opposition memorandum, DLA Piper’s work product, the defendant’s ex parte submission regarding the DLA Piper documents, and the representations made to the Court during the ex parte hearing with the DLA Piper attorneys who participated in the interviews, the Court concludes for the following reasons that the motion to quash must be granted in part and denied in part, based on the finding that the defendant is entitied to excerpts from DLA Piper’s interview notes and memoranda.

I. Background

The defendant is a former Major League Baseball (“MLB”) player who played for four different teams over a span of twenty-four years. See Indict, at 2. “In or about March 2005,” the United States House of Representatives — specifically, the House Committee on Oversight and Government Reform (the “Committee”)— conducted an investigation into “the use of [performance-enhancing drugs] in professional baseball.” Id. at 7. “[T]he Commissioner of MLB, partially in response to concerns raised by the Committee during its 2005 [investigation], engaged former ... United States Senator ... George J. Mitchell ... to conduct a comprehensive investigation of [performance-enhancing drug] use in MLB. Id. at 8. Senator Mitchell, who at the time of the engagement was a partner at DLA Piper, retained his law firm to represent him during the investigation. See June 8, 2011 Hearing Transcript (“6/8/11 Hr’g Tr.”) at 5:20-21 (“Senator Mitchell ... retained [DLA Piper] to represent him.”); 2 id. at 5:23-6:2 (“[T]he way the contracts were set up is that baseball retained him to do an investigation, [and] he then retained [DLA Piper] to act as his legal counsel____”). “On or about December 13, 2007, Senator Mitchell issued a 409-page report,” commonly referred to as the “Mitchell Report,” which “contained multiple allegations of [performance-enhancing] drug use in MLB over the years preceding its release.” Indict, at 8. Among the allegations contained in the Mitchell Report were claims that the de *239 fendant “used anabolic steroids on multiple occasions in 1998, 2000, and 2001,” as well as human-growth hormone (“HGH”) “on multiple occasions in 2000.” Id. In response to the allegations made in the Mitchell Report, the defendant appeared before the Committee for a deposition “on or about February 5, 2008,” and a hearing “on or about February 13, 2008,” during which he denied using performance-enhancing drugs. Id. at 10-11. According to the government, the defendant made statements before the Committee that he “knew to be false and misleading,” and it is these statements that are the subject of the criminal charges currently pending against him. See generally id. at 12-19.

As noted above, the defendant served DLA Piper with a subpoena duces tecum, in which it demanded production of, inter alia, various interview notes and memoranda pertaining to Jose Canseco, Kirk Radomski, and Brian McNamee. See DLA Piper’s Mem., Ex. 3 (Subpoena Duces Tecum to DLA Piper U.S. LLP) at 3. DLA Piper moved to quash the subpoena on March 18, 2011. See DLA Piper’s Mem. at 1. On April 21, 2011, the Court conducted a hearing on the merits of DLA Piper’s motion to quash the subpoena, and after considering the arguments raised by the parties at the hearing and in their written submissions, the Court concluded that the notes and memoranda at issue were prepared in anticipation of litigation, and thus they were entitled to protection as attorney work product. April 21, 2011 Hearing Transcript (“4/21/11 Hr’g Tr.”) at 83:8-11. Furthermore, the Court concluded that due to the government’s involvement with the interviews of Mr. Radomski and Mr. McNamee (but not Mr. Canseco), 3 the defendant may be entitled to some portions of DLA Piper’s work product. 4 See id. at 85:5-10 (noting that the work product with regard to Mr. Canseco is in a different posture from the materials regarding Mr. Radomski and Mr. McNamee); id. at 89:9-14 (ruling that “substantially verbatim” statements made by either Mr. Radomski or Mr. McNamee “should ... be made available to” the defendant). The Court reserved its ruling on this issue, however, and instead directed DLA Piper to produce for its in camera inspection “all documents responsive to the subpoena duces tecum that involved an interview by DLA Piper of either [Mr.] McNamee or [Mr.] Radomski while in the presence of government attorneys or investigators.” April 27, 2011 Order at 1-2, United States v. Clemens, Criminal Action No. 10-223(RBW) (D.D.C.). 5 The Court later explained in its April 27, 2011 Order that

[t]he first step in the Court’s review will be to determine whether the documents at issue constitute “opinion work prod *240 uct” or “fact work product.” 6 If the Court determines that the documents fall within the category of “opinion work product,” then the Court will not order DLA Piper to produce these documents to the defendant. On the other hand, if the Court concludes that the documents, or portions thereof, constitute “fact work product” because they contain substantially verbatim statements of Mr. McNamee or Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Clemens, 793 F. Supp. 2d 236, 2011 U.S. Dist. LEXIS 66554, 2011 WL 2489743 (D.D.C. 2011).

793 F. Supp. 2d 236 (United States v. Clemens) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Sutton
District of Columbia, 2022
Mischler v. Novagraaf Group Bv
District of Columbia, 2019
United States v. Stone
District of Columbia, 2019
United States ex rel. Bibby v. Wells Fargo Bank, N.A.
165 F. Supp. 3d 1319 (N.D. Georgia, 2015)
United States v. Trabelsi
District of Columbia, 2015
Landis v. Tailwind Sports Corporation
District of Columbia, 2015
United States Ex Rel. Barko v. Halliburton Co.
75 F. Supp. 3d 532 (District of Columbia, 2014)
United States Ex Rel. Landis v. Tailwind Sports Corp.
303 F.R.D. 419 (District of Columbia, 2014)
United States of America v. Iss Marine Services, Inc.
905 F. Supp. 2d 121 (District of Columbia, 2012)
Judicial Watch, Inc. v. United States Department of Justice
800 F. Supp. 2d 202 (District of Columbia, 2011)